Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development

Author： Barrett P Noel   Portsmouth Daniel   Ehrlich Hartmut J  

Publisher： Informa Healthcare

ISSN： 1476-0584

Source： Expert Review of Vaccines, Vol.12, Iss.4, 2013-04, pp. : 395-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Unique biomarkers for B-cell function predict the serum response to pandemic H1N1 influenza vaccine

By Frasca Daniela   Diaz Alain   Romero Maria   Phillips Mitch   Mendez Nicholas V.   Landin Ana Marie   Blomberg Bonnie B.  

International Immunology, Vol. 24, Iss. 3, 2012-03 ,pp. : 175-182

Oxford University Press

Access to resources Recommend Favorite

Overview of Cell-Based Tools for Pre-Clinical Assessment of Immunogenicity of Biotherapeutics

By Kropshofer Harald   Singer Thomas  

Journal of Immunotoxicology, Vol. 3, Iss. 3, 2006-09 ,pp. : 131-136

Informa Healthcare

Access to resources Recommend Favorite

The threat of avian influenza A (H5N1). Part IV: development of vaccines

By Cinatl jr Jindrich  

Medical Microbiology and Immunology, Vol. 196, Iss. 4, 2007-12 ,pp. : 213-225

Springer Publishing Company

Access to resources Recommend Favorite

Immunological assessment of influenza vaccines and immune correlates of protection

By Reber Adrian   Katz Jacqueline  

Expert Review of Vaccines, Vol. 12, Iss. 5, 2013-05 ,pp. : 519-536

Informa Healthcare

Access to resources Recommend Favorite

Novel swine-origin influenza A virus in humans: another pandemic knocking at the door

By Michaelis Martin  

Medical Microbiology and Immunology, Vol. 198, Iss. 3, 2009-08 ,pp. : 175-183

Springer Publishing Company

Access to resources Recommend Favorite